公开(公告)号：US09465031B2

公开(公告)日：2016-10-11

申请号：US12971419

申请日：2010-12-17

申请人： Naoyuki Okamoto ,  Takeshi Miura ,  Yohei Miyagi ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Takayuki Tanaka ,  Takahiko Muramatsu ,  Toshihiko Ando ,  Noriko Takahashi

发明人： Naoyuki Okamoto ,  Takeshi Miura ,  Yohei Miyagi ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Takayuki Tanaka ,  Takahiko Muramatsu ,  Toshihiko Ando ,  Noriko Takahashi

IPC分类号： G01N33/48 ,  G01N33/574 ,  G01N33/68

CPC分类号： G01N33/57434 ,  G01N33/6812 ,  G01N2800/342

摘要： According to the method of evaluating prostatic disease of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of prostatic disease including at least one of prostatic cancer and prostatic hypertrophy in the subject is evaluated based on the concentration value of at least one of Tau, Thr, Ser, Asn, Glu, Pro, Gly, Ala, Cit, ABA, Val, Met, Ile, Leu, Phe, His, Trp, Orn, Lys, and Cys2 contained in the measured amino acid concentration data of the subject.

摘要翻译： 根据本发明的前列腺疾病的评价方法，测定从被评价对象收集的血液中的氨基酸的浓度值的氨基酸浓度数据，前列腺疾病的状态，包括前列腺癌和前列腺中的至少一种 基于Tau，Thr，Ser，Asn，Glu，Pro，Gly，Ala，Cit，ABA，Val，Met，Ile，Leu，Phe，His，Trp中的至少一种的浓度值来评价受试者的肥大， Orn，Lys和Cys2包含在受试者的测量的氨基酸浓度数据中。

公开(公告)号：US20110138889A1

公开(公告)日：2011-06-16

申请号：US12971419

申请日：2010-12-17

申请人： Naoyuki Okamoto ,  Takeshi Miura ,  Yohei Miyagi ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Takayuki Tanaka ,  Takahiko Muramatsu ,  Toshihiko Ando ,  Noriko Takahashi

发明人： Naoyuki Okamoto ,  Takeshi Miura ,  Yohei Miyagi ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Takayuki Tanaka ,  Takahiko Muramatsu ,  Toshihiko Ando ,  Noriko Takahashi

IPC分类号： G01N30/02

CPC分类号： G01N33/57434 ,  G01N33/6812 ,  G01N2800/342

摘要： According to the method of evaluating prostatic disease of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of prostatic disease including at least one of prostatic cancer and prostatic hypertrophy in the subject is evaluated based on the concentration value of at least one of Tau, Thr, Ser, Asn, Glu, Pro, Gly, Ala, Cit, ABA, Val, Met, Ile, Leu, Phe, His, Trp, Orn, Lys, and Cys2 contained in the measured amino acid concentration data of the subject.

摘要翻译： 根据本发明的前列腺疾病的评价方法，测定从被评价对象收集的血液中的氨基酸的浓度值的氨基酸浓度数据，前列腺疾病的状态，包括前列腺癌和前列腺中的至少一种 基于Tau，Thr，Ser，Asn，Glu，Pro，Gly，Ala，Cit，ABA，Val，Met，Ile，Leu，Phe，His，Trp中的至少一种的浓度值来评价受试者的肥大， Orn，Lys和Cys2包含在受试者的测量的氨基酸浓度数据中。

公开(公告)号：US20110143444A1

公开(公告)日：2011-06-16

申请号：US12968578

申请日：2010-12-15

申请人： Takahiko Muramatsu ,  Yutaka Ihata ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Etsuko Miyagi ,  Fumiki Hirahara

发明人： Takahiko Muramatsu ,  Yutaka Ihata ,  Akira Imaizumi ,  Hiroshi Yamamoto ,  Etsuko Miyagi ,  Fumiki Hirahara

IPC分类号： G01N33/68 ,  G06F19/00

CPC分类号： G16B40/00 ,  G01N33/57411 ,  G01N33/57442 ,  G01N33/57449

摘要： According to the method of evaluating female genital cancer of the present invention, amino acid concentration data on concentration values of amino acids in blood collected from a subject to be evaluated is measured, and the state of female genital cancer including at least one of cervical cancer, endometrial cancer, and ovarian cancer in the subject is evaluated based on the concentration value of at least one of Thr, Ser, Asn, Gln, Pro, Gly, Ala, Cit, Val, Met, Ile, Leu, Tyr, Phe, His, Trp, Orn, Lys, and Arg contained in the measured amino acid concentration data of the subject.

摘要翻译： 根据本发明的女性生殖器癌的评价方法，测定从被评价对象收集的血液中的氨基酸的浓度值的氨基酸浓度数据，包括宫颈癌中的至少一种的女性生殖器癌的状态 基于Thr，Ser，Asn，Gln，Pro，Gly，Ala，Cit，Val，Met，Ile，Leu，Tyr，Phe中的至少一种的浓度值来评估受试者的子宫内膜癌和卵巢癌， His，Trp，Orn，Lys和Arg包含在受试者的测量的氨基酸浓度数据中。